Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ÆÄ¸Ó½´Æ¼Äà > ¾È°ú±â±â > U.S. Leading Ophthalmic Diseases Markets
Ä«Å×°í¸®
ÆÄ¸Ó½´Æ¼Äà (4931)
°¨¿°Áúȯ (349)
°ñÁúȯ Ä¡·á (38)
´ç´¢º´ (194)
¹é½Å (181)
ºñ¸¸Ä¡·á/´ÙÀÌ¾îÆ® (44)
ºñó¹æ ÀǾàǰ (152)
¼öÀÇÇÐ (17)
½Å°æÁúȯ (174)
½Å¾à°³¹ß (1529)
¾ÏÄ¡·á (941)
¾à¹°Àü´Þ (185)
ÀǾàǰ ±ÔÁ¦È¯°æ (127)
Á¤½ÅÁúȯ (86)
Á¦³×¸¯ ÀǾàǰ (128)
Á¦¾àȸ»çºÐ¼® (523)
󹿾à (165)
½ÃÀ庸°í¼­

U.S. Leading Ophthalmic Diseases Markets

¸®¼­Ä¡»ç Frost & Sullivan
¹ßÇàÀÏ 2006³â 03¿ù »óǰÄÚµå 37382
ÆäÀÌÁö Á¤º¸
°¡°Ý
US $ 6,000 £Ü 7,149,000 Web Access (Regional License)
US $ 6,500 £Ü 7,744,700 Hard Copy & Web Access (Regional License)


¿µ¹®¸ñÂ÷

Abstract

This Frost & Sullivan research service entitled U.S. Ophthalmic Pharmaceuticals Markets addresses patient dynamics and forecasts, product analysis, competitor and pipeline analysis, and market revenue forecasts for age-related macular degeneration (AMD), chronic dry eye, ocular allergy and ocular NSAID markets.

This analysis is available through our Pharmaceutical & Biotechnology Growth Partnership Services program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.

Table of Contents

1 EXECUTIVE SUMMARY

  • Executive Summary
    • Executive Summary

2 TOTAL U.S. LEADING OPHTHALMIC DISEASES MARKET

  • Market Scope and Methodology
    • Introduction
    • Scope and Segmentation
    • Research Methodology
    • Market Engineering Measurements
    • Glossary
    • Revenue Forecast
  • Market Trends
    • Market Drivers
    • Market Restraints
  • Industry Challenges and Strategic Recommendations
    • Industry Challenges
    • Strategic Recommendations
  • Competitive Structure
    • Competitive Landscape
    • Competitor Profiles
    • Market Share Analysis
  • Frost & Sullivan Awards for the U.S. Leading Ophthalmic Diseases Markets
    • Marketing Strategy Leadership of the Year Award
    • Industry Innovation Advancement of the Year Award
    • Company of the Year Award
    • Product Differentiation Innovation of the Year Award

3 U.S. AGE-RELATED MACULAR DEGENERATION MARKET

  • Overview
    • Introduction
    • Market Engineering Measurements
    • Product Analysis
    • Pipeline Analysis
  • Market Forecasts
    • Prevalent and Treatment AMD Patient Forecast
    • Total AMD Revenue Forecast and Assumptions
    • Product Sales Forecasts
    • Market Share Analysis

4 U.S. OCULAR ALLERGY MARKET - ALLERGIC CONJUNCTIVITIS

  • Overview
    • Introduction
    • Market Engineering Measurements
    • Product Analysis
    • Pipeline Analysis
  • Market Forecasts
    • Prevalent and Treated Ocular Allergy Patient Forecast
    • Total Ocular Allergy Revenue Forecast
    • Market Share Analysis

5 U.S. OCULAR NSAIDS MARKET

  • Overview
    • Introduction
    • Market Engineering Measurements
    • Product Analysis
    • Pipeline Analysis
  • Market Forecasts
    • Prevalent and Treated Ocular Inflammation Patient Forecast
    • Total Ocular Inflammation Revenue Forecast
    • Market Share Analysis

6 U.S. DRY EYE MARKET

  • Overview
    • Introduction
    • Market Engineering Measurements
    • Product Analysis
    • Pipeline Analysis
  • Market Forecasts
    • Prevalent and Treated Dry Eye Patient Forecast
    • Total Dry Eye Revenue Forecast
    • Market Share Analysis

7 APPENDIX

  • Decision Support Databases
    • Total Population
    • Total Healthcare Expenditure
    • Pharmaceutical R&D Expenditure
    • Pharmaceutical R&D Expenditure as a Percent of the Pharmaceutical Market
    • Glaucoma Prevalence
Back to Top